BiomX Inc.

06/28/2022 | Press release | Distributed by Public on 06/27/2022 23:44

8K-Dosing of the First Two Patients in Phase 1b/2a Study of BX004 for Treatment of Chronic Respiratory Infections in Patients with Cystic Fibrosis

Read this content
The text version of this document is not available. You can access the original document here.